These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22429520)

  • 1. Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer.
    Patsis C; Yiotakis I; Scorilas A
    Clin Biochem; 2012 Jun; 45(9):623-30. PubMed ID: 22429520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
    J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
    Foteinou E; Kontos CK; Giotakis AI; Scorilas A
    Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
    Kontos CK; Papadopoulos IN; Scorilas A
    Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
    Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
    Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.
    Stavropoulou P; Gregorakis AK; Plebani M; Scorilas A
    Clin Chim Acta; 2005 Jul; 357(2):190-5. PubMed ID: 15893744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy.
    Scorilas A; Gregorakis AK
    Biol Chem; 2006 Jun; 387(6):789-93. PubMed ID: 16800741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
    Planque C; Aïnciburu M; Heuzé-Vourc'h N; Régina S; de Monte M; Courty Y
    Biol Chem; 2006 Jun; 387(6):783-8. PubMed ID: 16800740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.
    Shi Y; Gong HL; Zhou L; Tian J; Wang Y
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients.
    Alexopoulou DK; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Biomark Med; 2014; 8(5):671-85. PubMed ID: 25123036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis and study of KLK4 in benign and malignant breast tumours.
    Papachristopoulou G; Avgeris M; Scorilas A
    Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
    Avgeris M; Stravodimos K; Scorilas A
    Prostate; 2011 Dec; 71(16):1780-9. PubMed ID: 21520157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
    Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
    Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues.
    Yang B; Chen J; Zhang X; Cao J
    Auris Nasus Larynx; 2009 Dec; 36(6):682-7. PubMed ID: 19427146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients.
    Jamaspishvili T; Scorilas A; Kral M; Khomeriki I; Kurfurstova D; Kolar Z; Bouchal J
    Neoplasma; 2011; 58(4):298-303. PubMed ID: 21520985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma.
    Georgiou A; Gomatos IP; Ferekidis E; Syrigos K; Bistola V; Giotakis J; Adamopoulos G; Androulakis G
    Eur J Surg Oncol; 2001 Sep; 27(6):574-80. PubMed ID: 11520092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.